Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Free Report) SVP Mary Beth Fritz sold 2,540 shares of the stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $58.92, for a total transaction of $149,656.80. Following the transaction, the senior vice president now owns 15,934 shares in the company, valued at $938,831.28. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Prestige Consumer Healthcare Trading Down 1.6 %
Shares of NYSE:PBH opened at $57.88 on Friday. Prestige Consumer Healthcare Inc. has a fifty-two week low of $48.51 and a fifty-two week high of $68.54. The firm has a 50-day simple moving average of $61.00 and a 200 day simple moving average of $60.35. The company has a quick ratio of 1.51, a current ratio of 2.66 and a debt-to-equity ratio of 0.89.
Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) last posted its earnings results on Thursday, August 3rd. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $1.01 by $0.05. The company had revenue of $279.31 million during the quarter, compared to analyst estimates of $278.79 million. Prestige Consumer Healthcare had a positive return on equity of 13.47% and a negative net margin of 7.46%. The business’s revenue was up .8% compared to the same quarter last year. During the same period in the prior year, the company earned $1.09 earnings per share. On average, sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.31 EPS for the current year.
Institutional Inflows and Outflows
Analyst Ratings Changes
PBH has been the topic of several research analyst reports. 3M reaffirmed a “reiterates” rating on shares of Prestige Consumer Healthcare in a research report on Monday, June 26th. TheStreet downgraded Prestige Consumer Healthcare from a “b” rating to a “c+” rating in a report on Thursday, September 7th. Finally, StockNews.com started coverage on Prestige Consumer Healthcare in a report on Thursday, August 17th. They issued a “buy” rating for the company. One analyst has rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $82.00.
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
- Five stocks we like better than Prestige Consumer Healthcare
- How to Choose Top Rated Stocks
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- MarketBeat Week in Review – 9/11 – 9/15
- Best Restaurant Stocks to Invest in Now
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.